140 related articles for article (PubMed ID: 22120630)
1. Synthetic cyclohexenyl chalcone natural products possess cytotoxic activities against prostate cancer cells and inhibit cysteine cathepsins in vitro.
Deb Majumdar I; Devanabanda A; Fox B; Schwartzman J; Cong H; Porco JA; Weber HC
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):397-402. PubMed ID: 22120630
[TBL] [Abstract][Full Text] [Related]
2. Letter to the Editor on "Synthetic cyclohexenyl chalcone natural products possess cytotoxic activities against prostate cancer cells and inhibit cysteine cathepsins in vitro".
Kapoor S
Biochem Biophys Res Commun; 2012 Oct; 427(2):438. PubMed ID: 22989751
[No Abstract] [Full Text] [Related]
3. Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs.
Wang HM; Zhang L; Liu J; Yang ZL; Zhao HY; Yang Y; Shen D; Lu K; Fan ZC; Yao QW; Zhang YM; Teng YO; Peng Y
Eur J Med Chem; 2015 Mar; 92():439-48. PubMed ID: 25590864
[TBL] [Abstract][Full Text] [Related]
4. Solution phase synthesis of a combinatorial library of chalcones and flavones as potent cathepsin V inhibitors.
Alvim J; Severino RP; Marques EF; Martinelli AM; Vieira PC; Fernandes JB; da Silva MF; Corrêa AG
J Comb Chem; 2010 Sep; 12(5):687-95. PubMed ID: 20578711
[TBL] [Abstract][Full Text] [Related]
5. Synthetic chalcone derivatives as inhibitors of cathepsins K and B, and their cytotoxic evaluation.
Ramalho SD; Bernades A; Demetrius G; Noda-Perez C; Vieira PC; Dos Santos CY; da Silva JA; de Moraes MO; Mousinho KC
Chem Biodivers; 2013 Nov; 10(11):1999-2006. PubMed ID: 24243608
[TBL] [Abstract][Full Text] [Related]
6. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.
Friedrich B; Jung K; Lein M; Türk I; Rudolph B; Hampel G; Schnorr D; Loening SA
Eur J Cancer; 1999 Jan; 35(1):138-44. PubMed ID: 10211102
[TBL] [Abstract][Full Text] [Related]
7. Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei brucei.
Troeberg L; Chen X; Flaherty TM; Morty RE; Cheng M; Hua H; Springer C; McKerrow JH; Kenyon GL; Lonsdale-Eccles JD; Coetzer TH; Cohen FE
Mol Med; 2000 Aug; 6(8):660-9. PubMed ID: 11055585
[TBL] [Abstract][Full Text] [Related]
8. Matrigel influences morphology and cathepsin B distribution of prostate cancer PC3 cells.
Gopal P; Rehman RU; Chadha KS; Qiu M; Colella R
Oncol Rep; 2006 Aug; 16(2):313-20. PubMed ID: 16820909
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
Kiat TS; Pippen R; Yusof R; Ibrahim H; Khalid N; Rahman NA
Bioorg Med Chem Lett; 2006 Jun; 16(12):3337-40. PubMed ID: 16621533
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antiplasmodial and falcipain-2 inhibitory activity of beta-amino alcohol thiolactone-chalcone and isatin-chalcone hybrids.
Hans RH; Gut J; Rosenthal PJ; Chibale K
Bioorg Med Chem Lett; 2010 Apr; 20(7):2234-7. PubMed ID: 20206517
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor activity of benzylideneacetophenone derivatives via proteasomal inhibition in prostate cancer cells.
Lee YH; Yun J; Jung JC; Oh S; Jung YS
Pharmazie; 2016 May; 71(5):274-9. PubMed ID: 27348972
[TBL] [Abstract][Full Text] [Related]
12. Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.
Brömme D; Klaus JL; Okamoto K; Rasnick D; Palmer JT
Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):85-9. PubMed ID: 8670136
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel synthetic chalcone derivatives as anti-tumor agents targeting Cat L and Cat K.
Wang Y; Xue S; Li R; Zheng Z; Yi H; Li Z
Bioorg Med Chem; 2018 Jan; 26(1):8-16. PubMed ID: 29223717
[TBL] [Abstract][Full Text] [Related]
14. Chalcone Derivatives: Role in Anticancer Therapy.
Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
[TBL] [Abstract][Full Text] [Related]
15. Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro.
James IE; Marquis RW; Blake SM; Hwang SM; Gress CJ; Ru Y; Zembryki D; Yamashita DS; McQueney MS; Tomaszek TA; Oh HJ; Gowen M; Veber DF; Lark MW
J Biol Chem; 2001 Apr; 276(15):11507-11. PubMed ID: 11148212
[TBL] [Abstract][Full Text] [Related]
16. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases.
Premzl A; Puizdar V; Zavasnik-Bergant V; Kopitar-Jerala N; Lah TT; Katunuma N; Sloane BF; Turk V; Kos J
Biol Chem; 2001 May; 382(5):853-7. PubMed ID: 11517941
[TBL] [Abstract][Full Text] [Related]
17. Effect of cysteine proteinase inhibitors on murine B16 melanoma cell invasion in vitro.
Sever N; Filipic M; Brzin J; Lah TT
Biol Chem; 2002 May; 383(5):839-42. PubMed ID: 12108549
[TBL] [Abstract][Full Text] [Related]
18. Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines.
Colella R; Goodwyn E; Gopal P
Cancer Lett; 2002 Nov; 185(2):163-72. PubMed ID: 12169390
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.
Kumar SK; Hager E; Pettit C; Gurulingappa H; Davidson NE; Khan SR
J Med Chem; 2003 Jul; 46(14):2813-5. PubMed ID: 12825923
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapy.
Rioux B; Pinon A; Gamond A; Martin F; Laurent A; Champavier Y; Barette C; Liagre B; Fagnère C; Sol V; Pouget C
Eur J Med Chem; 2021 Oct; 222():113586. PubMed ID: 34116328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
